References
- Hillner BE, Hollenberg JP, Pauker SG. Postmenopausal estrogens in prevention of osteoporosis: benefit virtually without risk if cardiovascular effects are considered. Am J Med 1986: 80(6): 1115–27
- Owen RA, Melton LJ 3d, Ilstrup DM, et al. Colles fracture and subsequent hip fracture risk. Clin Orthop 1982: 171: 37–43
- Wells RG. Hormone replacement before menopause: is it a good idea? Postgrad Med 1989: 86(6): 61–71
- Sarrel PM. Estrogen replacement therapy. Obstet Gynecol 1988: 72(5 Suppl): 2–5S
- Beauchamp PJ, Held B. Estrogen replacement therapy: universal remedy for the postmenopausal woman? Postgrad Med 1984: 75(7): 42–53
- Thorneycroft IH. The role of estrogen replacement therapy in the prevention of osteoporosis. Am J Obstet Gynecol 1989: 160(5 Pt 2): 1306–10
- Riggs BL, Seeman E, Hodgson SF, et al. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: comparison with conventional therapy. N Engl J Med 1982: 306(8): 446–50
- Luikin EG, Ory SJ. Estrogen replacement therapy for the prevention of osteoporosis. Am Fam Physician 1989: 40(3): 205–12
- Shargil AA. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Int J Fertil 1985: 30(1): 15, 18–28
- Projections of the population of the United States by age, sex, and race: 1983–2080. In: Bureau of Census current population reports. Series P-25 (952). Washington, DC: Bureau of the Census, 1984
- Fahraeus L. The effects of estradiol on blood lipids and lipoproteins in postmenopausal women. Obstet Gynecol 1988: 72(5 Suppl): 18–22S
- Brenner PF. The menopausal syndrome. Obstet Gynecol 1988: 72(5 Suppl): 6–11S
- Whitehead M. Oestrogens: relative potencies and hepatic effects after different routes of administration. J Obstet Gynecol 1982: 2(Suppl): 11–16S
- Droesch K, Navot D, Scott R, et al. Transdermal estrogen replacement in ovarian failure for ovum donation. Fertil Steril 1988: 50(6): 931–4
- Ryan KJ, Engel LL. The interconversion of estrone and estradiol by human tissue slices. Endocrinology 1953: 52: 287–91
- Murad F, Haynes RC Jr. Estrogens and progestins. In: Goodman AG, Gilman AS, Rall TW, et al, eds. The pharmacological basis of therapeutics. New York: Macmillan, 1985: 1412–39
- Lobo RA, Nguyen HN, Eggena P, et al. Biologic effects of equilin sulfate in postmenopausal women. Fertil Steril 1988: 49(2): 234–8
- Rudy DR. Osteoporosis: overcoming a costly and debilitating disease. Postgrad Med 1989: 86(2): 151–8
- Gambrell RD Jr. Menopause: benefits and risks of estrogen-progestin replacement therapy. Med Times 1989 Sep: 35–43
- Bergkvist L, Adami HO, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989: 321(5): 293–7
- Murray PP, Stadel BV, Schlesselman JJ. Oral contraceptive use in women with a family history of breast cancer. Obstet Gynecol 1989: 73(6): 977–83
- Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 1989: 161(6 Pt 2): 1859–64